Product Information
- 6-(2,6-dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one
Applications PD-173952 is a Bcr-Abl tyrosine kinase inhibitor used in treatment research for chronic myelegenous leukemia (CML).
References Dorsey, J.F. et al.: Leukemia, 16, 1589 (2002); Wisniewski, D. et al.: Canc. Res., 62, 4244 (2002); Mizenina, O.A. et al.: Cell Cycle, 3, 796 (2004);
Chemical properties
Technical inquiry about: TR-P217800 PD-173952
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.